In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...